Last Updated 3 October 2022.
7 Vaccines Approved for Use in Republic of Korea
-
SK Bioscience Co Ltd
SKYCovione- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 6 countries
Approval Source: ipd.uw.edu
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
Approval Source: reuters.com
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
Approval Source: modernatx.gcs-web.com
-
Moderna
Spikevax Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
3 trials in 3 countries
Approval Source: kukinews.com
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
97 trials in 31 countries
Approval Source: asia.nikkei.com
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: mfds.go.kr
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
71 trials in 33 countries
Approval Source: reuters.com
9 Vaccines in Clinical Trials in Republic of Korea
-
SK Bioscience Co Ltd
SKYCovione- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 6 countries
-
Inovio
INO-4800- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
10 trials in 9 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
71 trials in 33 countries
-
EuBiologics Co Ltd
EuCorVac-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
GeneOne Life Science, Inc.
GLS-5310- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Cellid Co
AdCLD-CoV19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 1 country
-
SK Bioscience Co Ltd
NBP2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
HK inno.N Corporation
IN-B009- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Cellid Co
AdCLD-CoV19-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
1 Vaccines with Trials in Republic of Korea are No Longer Progressing
-
Genexine
GX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
7 trials in 1 country